Vitrectomy, Subretinal Tissue Plasminogen Activator (TPA) and Intravitreal Gas for Submacular Haemorrhage Secondary to Exudative (Wet) Age-related Macular Degeneration (TIGER).
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Timothy L Jackson, PhD, FRCOphth
Kings College London & Kings College Hospital
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
36 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Bonn
Bonn, Germany
Kristina PfauRecruiting - University Medical Center Hamburg Eppendorf
Hamburg, Germany
Martin SpitzerRecruiting - Ludwig Maximilians-University München
München, Germany
Siegfried PriglingerRecruiting - Augenzentrum Am St. Franziskus-Hospital Münster
Münster, Germany
Albrecht LommatzschRecruiting - Knappschaft Kliniken Saar Gmbh, Sulzbach
Sulzbach, Germany
Boris StanzelRecruiting - Ulm University Hospital
Ulm, Germany
Armin WolfRecruiting - University Hospital of Würzburg
Würzburg, Germany
Jost HillenkampRecruiting
- the Institute of Eye Surgery
Waterford, Ireland
Eugene NgRecruiting
- Ophthalmology Clinic Jasne Błonia
Lodz, Poland
Zofia Anna NawrockaRecruiting
- University Hospital Bern
Bern, Switzerland
Martin Sebastian ZinkernagelRecruiting
- Mid and South Essex Nhs Foundation Trust
Chelmsford, Essex, United Kingdom
Raiji KoothoorRecruiting - Kent & Canterbury Hospital (east Kent University)
Canterbury, Kent, United Kingdom
Yvonne LuoRecruiting - King'S College Hospital Nhs Foundation Trust
London, London, United Kingdom
Timothy L Jackson, PhD, FRCOphthRecruiting - the Princess Alexandra Eye Pavilion
Edinburgh, Scotlan, United Kingdom
Manjit MehatRecruiting - Sunderland Eye Infimary
Sunderland, Tyne and Wear, United Kingdom
Jonathan SmithRecruiting - Hull Royal Infirmary
Hull, Yorkshire, United Kingdom
Abdallah EllabbanRecruiting - Belfast Health and Social Care Trust
Belfast, United Kingdom
Noemi LoisRecruiting - University Hospitals Sussex Nhs Trust
Brighton, United Kingdom
Withdrawn - Bristol Eye Hospital
Bristol, United Kingdom
Johannes KellerRecruiting - Royal Devon and Exeter Hospital
Exeter, United Kingdom
Conor RamsdenRecruiting - Gartnavel General Hospital
Glasgow, United Kingdom
Withdrawn - Leicester Royal Infirmary
Leicester, United Kingdom
Somnath BanerjeeRecruiting - Royal Liverpool University Hospital
Liverpool, United Kingdom
Ruman HussainRecruiting - Barts Health Nhst Trust - Whipps Cross University Hospital
London, United Kingdom
Hadi ZambarakjiRecruiting - Imperial College Healthcare Nhs Foundation Trust (the Western Eye Hospital)
London, United Kingdom
Rahila ZakirRecruiting - Moorfields Eye Hospital
London, United Kingdom
Louisa WickhamRecruiting - Maidstone and Tunbridge Wells Nhs Trust
Maidstone, United Kingdom
Luke MembreyRecruiting - Manchester Royal Eye Hospital
Manchester, United Kingdom
Tsveta IvanovaRecruiting - James Cook University Hospital, (south Tees Nhsft)
Middlesbrough, United Kingdom
Saad AhmedRecruiting - Royal Victoria Infirmary
Newcastle upon Tyne, United Kingdom
Roxane HillierRecruiting - Nottingham University Hospitals
Nottingham, United Kingdom
Alexander FossRecruiting - Oxford University Hospitals Nhs Foundation Trust
Oxford, United Kingdom
Sher AslamRecruiting - University Hospitals Plymouth Nhst
Plymouth, United Kingdom
Vasant RamanRecruiting - University Hospital Southampton Nhs Foundation Trust
Southampton, United Kingdom
Bhaskar GuptaRecruiting - Torbay and South Devon Nhs
Torquay, United Kingdom
Eddie DoyleRecruiting - New Cross Hosp, Royal Wolverhampton Nhst
Wolverhampton, United Kingdom
Kam BalagganRecruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 16 Apr 2021
- Primary completion
- 31 Dec 2028
- Completion
- 31 Dec 2028
- Last update posted
- 15 May 2026
- Registered enrollment
- 210
- Registry id
- NCT04663750
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.